Impact of Enhanced Recovery After Surgery (ERAS) Combined with Bariatric Surgery Targeting Opioid Prescriptions (BSTOP) Protocol on Patient Outcomes, Length of Stay and Opioid Prescription After Bariatric Surgery

• Published in: Obesity surgery Vol. 33; no. 10; pp. 3206 - 3211
• Main Authors: Silverstein, Jeffrey, Sohail, Amir H., Silva-Pacheco, Tulio B., Khayat, Adam, Amodu, Leo, Cherasard, Patricia, Levine, Jun, Goparaju, Anirudha, Kella, Venkata, Shahidul, Islam, Petrone, Patrizio, Brathwaite, Collin E. M.
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.10.2023; Springer Nature B.V
• Subjects: Gastrointestinal surgery; Length of stay; Medicine; Medicine & Public Health; Narcotics; Original Contributions; Recovery (Medical); Surgery; BSTOP; Bariatric surgery; ERAS
• ISSN: 0960-8923; 1708-0428
• DOI: 10.1007/s11695-023-06794-x

Background Evidence shows that 14.2% of opioid-naive patients have long-term opioid dependence after bariatric surgery. Enhanced recovery after surgery (ERAS) protocols are widely used in bariatric surgery, while bariatric surgery targeting opioid prescriptions (BSTOP) protocols were recently introduced. We will investigate the combined impact of ERAS and BSTOP protocols after bariatric surgery. Methods We conducted a retrospective review for patients who underwent either a sleeve gastrectomy or Roux-en-Y gastric bypass at a tertiary care center. Pre-intervention and post-intervention data were compared. Primary outcomes were length of stay (LOS), 30-day readmission, 30-day complications, and discharge on opioids. Multivariate Poisson regression with robust standard error was used to analyze LOS. Results There was no significant difference in 30-day emergency room visits (3.3% vs. 4.0%; p value = 0.631), 30-day readmission (4.4% vs. 5.4%; p value = 0.577) or 30-day complication rate (4.2% vs. 6.4%; p value = 0.199). LOS was significantly lower in the post-intervention group; mean (interquartile range) 2 (1–2) days vs. 1 (1–2) day, p value < 0.001. On multivariate analysis, the post-intervention group had 0.74 (95% confidence interval 0.65–0.85; p value < 0.001) times lower LOS as compared to pre-intervention group. Patients with DM had a significantly longer LOS (relative risk: 1.22; p  = 0.018). No other covariates were associated with LOS ( p value < 0.05 for all). BSTOP analysis found a significant difference between the two groups. Discharge on opioids decreased from 40.6% pre-intervention to 7.1% post-intervention. Conclusion ERAS and BSTOP protocols reduced length of stay and opioid need at discharge without an increase in complication or readmission rates. Graphical Abstract